Heres what the clinical data shows: Most Common: Nausea (affecting 15-44% of users), diarrhea (10-30%), vomiting (7-25%), and constipation (6-24%) Severity: 98.1% of gastrointestinal side effects are mild or moderate, with 99.5% being non-serious Duration: Median duration is 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting Timing: Most side effects occur during initial weeks and dose escalation, declining over time Discontinuation: Only 4.3-10% of users discontinue therapy due to side effects Serious Events: Rare, with no increased risk of pancreatitis or malignancy in clinical trials Management: Slow dose titration, dietary modifications, and hydration significantly reduce symptoms Important Note: Weight loss is NOT caused by side effects
Stable for 24+ months
Manufacturing occurs in facilities that undergo continuous FDA inspection with validated processes that ensure batch-to-batch consistency
Doses of IV Glutathione injections can range anywhere from 2-4 grams for most patients
The company has launched small-portion, high-protein frozen meals with a GLP-1-friendly badge to tap into this growing consumer trend
Acknowledgements This study was funded by Eli Lilly and Company